The iQ Group Global has been recognised by Med Tech Outlook magazine as one of the Top 10 Diabetes Care Solutions Providers in 2019.
The Saliva Glucose Biosensor is the world’s first non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood.
With this world-first technology, our global mission is to free people living with diabetes from painful and invasive blood monitoring devices, giving them a better quality of life.
For more on our plans to revolutionise diabetes management in China, visit glucosebiosensor.com
For the full article visit https://diabetes-care.medicaltechoutlook.com/vendors/top-diabetes-care-companies.html